Nitrous Acid

Nitrous Acid

SCHEMBL23748565

Nc1ncco1.O=NO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL163433 0.85
Hydrochloric Acid SCHEMBL9425516 0.83
Fluoride SCHEMBL27850618 0.83
Formic Acid SCHEMBL3423113 0.82
Benzene SCHEMBL28179804 0.80 HSP90AA1 (0.36)
Trifluoroacetic Acid SCHEMBL25401305 0.75 L3MBTL1 (0.38)
Trifluoromethanesulfonic Acid SCHEMBL30805625 0.74 CFTR (0.33)
Pyrimidine SCHEMBL28940749 0.73 HSP90AA1 (0.34)
Thiophene SCHEMBL27622194 0.71 ALDH1A1 (0.32)
Serine SCHEMBL312921 0.70 ARG1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12545652-B2 Crystalline forms of a TYK2 inhibitor SAREUM LIMITED (GB) 2026-02-10 US disclosed
EP-3864009-B1 TYK2 KINASE INHIBITORS SAREUM LTD (GB) 2025-02-19 EP disclosed
US-12187716-B2 TYK2 kinase inhibitors SAREUM LIMITED (GB) 2025-01-07 US disclosed
US-20230159473-A1 CRYSTALLINE FORMS OF A TYK2 INHIBITOR SAREUM LIMITED (GB) 2023-05-25 US disclosed
EP-4132649-A1 CRYSTALLINE FORMS OF A TYK2 INHIBITOR Sareum Limited (GB) 2023-02-15 EP disclosed
US-20210387981-A1 TYK2 KINASE INHIBITORS SAREUM LIMITED (GB) 2021-12-16 US disclosed
EP-3864009-A1 TYK2 KINASE INHIBITORS Sareum Limited (GB) 2021-08-18 EP disclosed